Drug Research
Drug Delivery

Drug Delivery News

View news from other Pharmaceutical sectors:
1-15 of 2327 results
Sorrento acquires lymphatic delivery technology platform from Kimberly-Clark
Sorrento Therapeutics has acquired Kimberly-Clark’s Sofusa lymphatic delivery technology platform for targeted biopharmaceuticals, particularly, the immune checkpoint inhibitors like anti-PD-1, CTLA4, CD47 antibodies and other I-O antibodies.
Drug Research > Drug Delivery > News
Novacap to acquire US-based CDMO PCI Synthesis
Novacap has agreed to acquire Boston-based PCI Synthesis, a pharmaceutical contract development and manufacturing organization (CDMO), for an undisclosed price.
Drug Research > Drug Delivery > News
Recipharm agrees to acquire Sanofi CMO business in UK
Recipharm has agreed to acquire Sanofi CMO business in the UK for a consideration of £45m, in a bid to expand its inhalation capabilities.
Drug Research > Drug Delivery > News
Virpax licenses LipoCure’s Liposome drug delivery technology
Virpax Pharmaceuticals has signed a technology license agreement with LipoCure to develop pain management products using the latter’s liposome drug delivery technology.
Drug Research > Drug Delivery > News
OptiBiotix Health signs manufacturing and supply deal in India with Akums
OptiBiotix Health has entered into a five year agreement with Akums Drugs and Pharmaceuticals to exclusively manufacture and supply products featuring OptiBiotix's cholesterol and blood pressure reducing strain LPLDL in India.
Drug Research > Drug Delivery > News
AstraZeneca to sell Seroquel drug rights to Luye Pharma for $538m
By PBR Staff Writer
AstraZeneca has agreed to sell the rights to its Seroquel schizophrenia treatment to China-based Luye Phara for $538m.
Drug Research > Drug Delivery > News
Lannett buys 23 generic drug products from Endo subsidiary
Lannett has acquired 23 approved and one pending drug product applications from a subsidiary of Endo International for an undisclosed amount along with future milestone payments.
Drug Research > Drug Delivery > News
Vivus to acquire product rights to Pancreaze from Janssen for $135m
Vivus has agreed to acquire all product rights for Pancreaze (pancrelipase) Delayed-Release Capsules in the US and Canada held by Janssen Pharmaceuticals, subject to certain closing conditions, including Hart-Scott-Rodino review.
Drug Research > Drug Delivery > News
Ani Pharmaceuticals to buy generic products from Amneal and Impax
By PBR Staff Writer
Ani Pharmaceuticals has agreed to acquire a portfolio of generic products and other assets from Amneal Pharmaceuticals and Impax Laboratories for an undisclosed sum.
Drug Research > Drug Delivery > News
Eidos Therapeutics raises $64m for transthyretin amyloidosis therapy
Eidos Therapeutics has completed $64m in Series B funding to support phase 2 clinical trials of AG10, a best-in-class therapy for transthyretin amyloidosis, and ongoing preparation for phase 3 clinical trials.
Drug Research > Drug Delivery > News
Biogen to acquire Pfizer’s schizophrenia drug for up to $590m
By PBR Staff Writer
Biogen has agreed to buy Pfizer's investigational schizophrenia drug, PF-04958242, in a deal worth about $590m.
Drug Research > Drug Delivery > News
JW Therapeutics secures $90m in new funding
Clinical stage biopharmaceutical firm JW Therapeutics has secured $90m Series A financing from a consortium led by Temasek, Sequoia Capital China, and YuanMing Capital.
Drug Research > Drug Delivery > News
Mylan to launch two new HIV combination treatments in US
Mylan said that it will launch two new HIV treatments, Symfi Lo and Cimduo, which have been approved in February this year by the US Food and Drug Administration (FDA).
Drug Research > Drug Delivery > News
LEO Pharma sells major product portfolio to Karo Pharma for €260m
LEO Pharma has sold product portfolio of 10 products to Swedish company Karo Pharma for €260m.
Drug Research > Drug Delivery > News
Teva launches QVAR RediHaler inhalation aerosol in US
Teva Pharmaceutical Industries has launched QVAR RediHaler™ (beclomethasone dipropionate HFA) Inhalation Aerosol in both 40mcg and 80mcg strengths in the US.
Drug Research > Drug Delivery > News
1-15 of 2327 results